ChromaDex Corp. (CDXC.OB) Receives $500,000 Grant to Commercialize Antioxidant Technology

QualityStocks would like to highlight ChromaDex (OTCBB: CDXC), a leader in the development of phytochemical and botanical reference standards and the creation of associated intellectual property. ChromaDex is committed to sustainable "green chemistry" and provides the dietary supplement, food, beverage, nutraceutical, and cosmetic industries, with the novel ingredients, analytical tools and services to meet product regulatory, quality, efficacy and safety standards. The company has worldwide exclusive patent rights related to pterostilbene.

In the company’s news yesterday,

ChromaDex Corp. announced that the National Science Foundation has awarded the company a $500,000 phase II Small Business Innovation Research (SBIR) Grant for the company’s project called “SBIR Phase II: Microbial Production of Selected Anthocyanins.”

The grant will enable the company to continue with the commercial development of several plant-based antioxidants called anthocyanins for use in nutraceutical, food, beverage and cosmetic products.

ChromaDex will combine the grant money with its own resources to complete validation of anthocyanins using its AnthoPure™ technology to meet growing demand for natural ingredients in the market place.

Bill Spengler, president of ChromaDex, said the funding is an important step in its business strategy and that the anthocyanins have promising potential for the company.

“The development of anthocyanins through our AnthoPure technology represents the next stage in our commercialization strategy of new and novel ingredients at ChromaDex,” Spengler stated in the press release. “This follows the development of pTeroPure™ pterostilbene, which is currently undergoing clinical trials for cholesterol reduction and oxidative stress at the University of Mississippi. We believe the revenue potential for select, high purity anthocyanins will be significant, but until recently there has not been a commercially viable process by which to manufacture them.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.